Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 8/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | CFTR | P13569 | 1/20 | 0.31 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19729785 | 0.94 | MEN1 (0.34) | RORCALDH1A1ADORA2APTGER4MEN1 | |
| SCHEMBL19729667 | 0.94 | MEN1 (0.34) | RORCALDH1A1ADORA2APTGER4MEN1 | |
| SCHEMBL19729681 | 0.91 | RORC (0.33) | PRKDCRORCPTGER4MEN1KMT2A | |
| SCHEMBL19737772 | 0.91 | RORC (0.33) | PRKDCRORCPTGER4MEN1KMT2A | |
| SCHEMBL19737705 | 0.91 | MEN1 (0.36) | ADRA2CALDH1A1ADORA2AMEN1KMT2A | |
| SCHEMBL19729680 | 0.90 | PDK2 (0.33) | PRKDCRORCPTGER4MEN1KMT2A | |
| SCHEMBL19737821 | 0.90 | PDK2 (0.33) | PRKDCRORCPTGER4MEN1KMT2A | |
| SCHEMBL19697995 | 0.88 | ADRA2C (0.42) | ADRA2CALDH1A1ADORA2ACFTRMEN1 | |
| SCHEMBL19729727 | 0.88 | MEN1 (0.38) | RORCADRA2CALDH1A1ADORA2APTGER4 | |
| SCHEMBL19737708 | 0.88 | MEN1 (0.38) | RORCADRA2CALDH1A1ADORA2APTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10957862-B2 | Condensed cyclic compound for organic light-emitting device, and organic light-emitting device including the compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-03-23 | — | — | US | disclosed |
| US-20170365796-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-21 | — | — | US | disclosed |
| US-20170365796-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170365796-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | PRKDC 4836/4885RORC 1161/4885ADRA2C 3107/4885 |
| US-10957862-B2 | Condensed cyclic compound for organic light-emitting device, and organic light-emitting device including the compound | CRY1, CRY2, OCIAD1 | PRKDC 4796/4885RORC 1214/4885ADRA2C 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.